Yes, Malaysia offers expedited registration pathways for certain drugs through the Conditional Registration Pathway and Priority Review Scheme. These pathways are designed to accelerate the approval process for drugs addressing unmet medical needs, serious conditions, or public health emergencies, ensuring timely access to essential medications for patients.
